The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Retrospective analysis of treatment-induced peripheral neuropathy (TIPN) in multiple myeloma (MM).
Thomas Martin
Research Funding - Sanofi
Sumeet Panjabi
Employment or Leadership Position - Onyx
Stock Ownership - Onyx
Robert Imani
Employment or Leadership Position - Onyx
Stock Ownership - Onyx
Emmanuel Anum
No relevant relationships to disclose
Deborah P. Lubeck
Consultant or Advisory Role - Onyx